Evidence map›Paper›PMID 42973796›Full record

ReviewFrontiers in psychiatry2026

Choosing depression treatment in type 2 diabetes: integrating psychiatric efficacy, metabolic effects, and cardiovascular risk. A narrative review.

Yanyan Tan, Yuchen Zhang, Lang Yuan, Fei Huang, Yanbin Cheng, Feng Cheng

Abstract readReview
In one paragraph

Review in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yanyan Tan *Clinical Laboratory, Ezhou Central Hospital, Ezhou, China.
Yuchen Zhang *School of Laboratory Medicine, Hubei University of Chinese Medicine, Wuhan, China.
Lang YuanClinical Laboratory, Ezhou Central Hospital, Ezhou, China.
Fei HuangClinical Laboratory, Ezhou Central Hospital, Ezhou, China.
Yanbin ChengSchool of Health and Nursing, Wuchang University of Technology, Wuhan, China.
Feng ChengClinical Laboratory, Ezhou Central Hospital, Ezhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Depression in people with type 2 diabetes (T2D) complicates daily self-management and treatment selection. Psychiatric benefit must be considered alongside weight, glycaemia, cardiovascular tolerability and interactions. This narrative review draws on purposively selected literature and distinguishes direct T2D evidence from mixed-diabetes studies, observational associations and indirect evidence. Study selection and extraction were not consistently duplicated, and no formal

Indexed as

antidepressantscardiometabolic riskcollaborative caredepressionpsychotherapyshared decision-makingtype 2 diabetes

Identifiers

PMID42973796
PMCPMC13725209

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.